Victor G. Soto, M.D.

Medical Director, Cardiac Imaging
Voluntary Assistant Professor in Internal Medicine, Cardiology Division

tel: 305-243-5554
fax: 305-243-5819

Education

Areas of Specialization

• Nuclear Cardiology
• Echocardiography
• Cardiac Imaging

Victor Soto, M.D., voluntary assistant professor of medicine in the Cardiovascular Division at the University of Miami Miller School of Medicine, will serve as the medical director of cardiac imaging.  Dr. Soto has received numerous awards in the community and has served as voluntary faculty at the Miller School for nearly a decade.

Dr. Soto earned his medical degree at the University of Panama and completed his residency in internal medicine and fellowship in cardiology at Jackson Memorial Hospital in Miami.  He is a member of the Florida Echocardiography Task Force for the American College of Cardiology and was the founder and president of the South Florida Society of Echocardiography.

Clinical Specialties

Research Interests

DEXA study AMG 785 20060220. A randomized, double-blind, placebo-controlled, ascending ascending single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 785 in healthy men and postmenopausal women. January to August 2007.

Merck # 004-01 / MK-0773 (06045). Bone Densitometry Study. September 2006- 2007

A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 vs. Adenoscan in Patients Undergoing Stress Myocardial Perfusion Imaging. (Protocol # CVT-5131). 2005 - 2006.

A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 vs. Adenoscan in Patients Undergoing Stress Myocardial Perfusion Imaging. (Protocol #CVT-5132). 2004-2005.

A Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NM-702 in Subjects with Intermittent Claudication. 2004.

ICPOP Study: The effect of Niacin ER/Lovastalin on peak walking time in patients with intermittent claudication.  Protocol MA-02-010403, US-1ND, Number 65,126.  2003.

CIS-US/Berlex TcN-NOET trial diagnostic potential of TcN-NOET in identify CAD during exercise and rest myocardial SPECT imaging (Phase III).  2001 – 2002.

Wyeth-Ayerst 3068A1-300.  New medication study on osteoporosis evaluated with dual energy x-ray absorptiometry (DEXA). 2001.

DPC 083-103, A Phase I Open-Label study in healthy male subjects to evaluate loading dose/maintenance dose requirements when DPC 083 is administered orally, DuPont Pharmaceuticals Company; February 12, 2001 – December 2001.                     

A multicenter, double-blind, randomized, parallel placebo-controlled study of the safety and efficacy of chronic oral Beraprost sodium in patient with intermittent claudication (Fontaine Stage II peripheral arterial occlusive disease; since Oct. 2000 – 2001.

Effects of Phen-fen on the heart - Echocardiographic evaluation.  Wyeth-Ayerst - Protocol 0927B2-916.  Miami, FL.; 1998-1999

Effects of a new hypoglycemic drug - Echocardiographic evaluation.  Takeda American Inc. - Pioglitazone (AD-4833) Study AD-4833/PNFP-001.1.  Miami, FL 1997 – 1998.

Efficacy and tolerability of Felodipine ER in the treatment of stage I (JNCV) systolic hypertension in older patients over a one-year period.  Astra Merck Inc.  Miami, FL 1996-1998.

Participant in the TIMI VIII.  Jackson Memorial Hospital, Miami, FL 1995.

Participant in the TIMI IV.  Jackson Memorial Hospital.  Miami, FL 1991-1992.

Publications

Awards & Recognition

• Sodi Award for ECG Interpretation
  The Sodi Award for ECG Interpretation, Section of Clinical Electrophysiology, University of Miami School of Medicine, Jackson Memorial Hospital; November 25, 1992.
• Letter of Appreciation
  Letter of Appreciation, Maxwell McKenzie, M.D., Chief - Internal Medicine Department, University of Miami School of Medicine, Jackson Memorial Hospital, 1992.
• Certificate of Appreciation from Mayor of Miami
  Certificate of Appreciation from Mayor Penelas, City of Miami, for the formation of the Central American Medical Society, November 1997.